AN2 Therapeutics, Inc. (ANTX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $8.89M | -13.2% |
| 2024 | $10.24M | -27.1% |
| 2023 | $14.04M | +95.4% |
| 2022 | $7.19M | +110.9% |
| 2021 | $3.41M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $8.89M | -13.2% |
| 2024 | $10.24M | -27.1% |
| 2023 | $14.04M | +95.4% |
| 2022 | $7.19M | +110.9% |
| 2021 | $3.41M | — |